500340-80-7

Upstream product

• 140-29-4 phenylacetonitrile 
• 68692-77-3 (1-phenylcyclohexyl)methanol 
• 124-63-0 methanesulfonyl chloride 
• 22612-69-7 1-phenylcyclohexane-1-carbaldehyde 
• 2201-23-2 1-phenyl-1-cyclohexanecarbonitrile 
• 111-24-0 1,5-dibromo-pentane 

Downstream Products

• 32294-72-7 (1-phenylcyclohexyl)acetonitrile 
• 1616924-42-5 9-benzyloxy-2-isopropyl-6-(1-phenylcyclohexylmethyl)-3,4-dihydro-2H-pyrazino[1,2-c]pyrimidine-1,8-dione 
• 1616924-41-4 5-benzyloxy-6-hydroxy-2-(1-phenylcyclohexylmethyl)pyrimidine-4-carboxylic acid (2-hydroxyethyl)isopropylamide 
• 1616924-40-3 5-benzyloxy-6-hydroxy-2-(1-phenylcyclohexylmethyl)pyrimidine-4-carboxylic acid [2-(tert-butyldimethylsilanyloxy)ethyl]isopropylamide 
• 1616924-39-0 5-benzyloxy-6-hydroxy-2-(1-phenylcyclohexylmethyl)pyrimidine-4-carboxylic acid 
• 1616924-38-9 5-benzyloxy-6-hydroxy-2-(1-phenylcyclohexylmethyl)pyrimidine-4-carboxylic acid tert-butyl ester 
• 1616924-37-8 2-(1-phenylcyclohexyl)acetamidine hydrochloride 
• 1616922-11-2 9-hydroxy-2-isopropyl-6-(1-phenylcyclohexylmethyl)-3,4-dihydro-2H-pyrazino[1,2-c]pyrimidine-1,8-dione 

Relevant academic research and scientific papers

PYRIMIDONE DERIVATIVES AND THEIR USE IN THE TREATMENT, AMELIORATION OR PREVENTION OF A VIRAL DISEASE

The present invention relates to a compound having the general formula (I), optionally in the form of a pharmaceutically acceptable salt, solvate, polymorph, codrug, cocrystal, prodrug, tautomer, racemate, enantiomer, or diastereomer or mixture thereof, which are useful in treating, ameloriating or preventing a viral disease. Furthermore, specific combination therapies are disclosed.